O'Connor John J. II 4
4 · SERACARE LIFE SCIENCES INC · Filed Apr 20, 2012
Insider Transaction Report
Form 4
O'Connor John J. II
VP, Sales and Marketing
Transactions
- Disposition to Issuer
Common Stock
2012-04-20−86,880→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger dated as of February 12, 2012, as amended by Amendment No. 1 to Agreement and Plan of Merger dated as of February 27, 2012, among SeraCare Life Sciences, Inc., Project Plasma Holdings Corporation and Project Plasma Merger Corp. the "Merger Agreement"), each share of SeraCare Life Sciences, Inc.'s common stock was exchanged for $4.00 in cash, without interest and less any applicable withholding taxes.